Is XBiotech Inc. overvalued?

XBiotech Inc. (XBIT) — key valuation metrics and fundamentals.

No verdict

Price

$2.15

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$65.5M

Dividend yield

0.0%

Return on equity

-31.6%

Sector

Healthcare

Fair value compares XBIT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks